STEMPOINT CAPITAL LP
Filing Date
Global Rank
#2,318
/ 8,604
▲ 24
· as of Mar 2026
Top Industry
Biotechnology
92.0%
3Y Alpha vs SPY
-4.3%
Period ended 3 months ago
Filed May 18, 2026 · 51d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+44.1%
SPY
+54.1%
Annualised alpha
-3.3%
Max drawdown
−45.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
75 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.9%
+0.6 pts
Top 5
30.8%
+1.3 pts
Top 10
45.7%
+0.2 pts
HHI
317
Diversified−0
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 90.6% | $565,958,783 |
| Unclassified | 8.9% | $55,604,200 |
| Financial Services | 0.5% | $3,099,084 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
21 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | +884,724 | 1,874,546 | $2,436,909 | |
| EYPT | EyePoint, Inc. | +456,915 | 810,764 | $10,450,747 | |
| MBX | MBX Biosciences, Inc. | +420,916 | 499,469 | $14,909,149 | |
| RVMD | Revolution Medicines, Inc. | +319,600 | 381,632 | $37,113,712 | |
| MLYS | Mineralys Therapeutics, Inc. | +243,329 | 533,378 | $14,449,210 | |
| SABS | SAB Biotherapeutics, Inc. | +228,442 | 375,000 | $1,436,250 | |
| IMVT | Immunovant, Inc. | +201,535 | 846,494 | $21,026,910 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +189,052 | 413,792 | $9,748,939 | |
| SYRE | Spyre Therapeutics, Inc. | +135,229 | 167,606 | $8,454,046 | |
| EVMN | Evommune, Inc. | +125,581 | 193,777 | $4,454,933 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +107,552 | 180,658 | $5,782,862 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +104,545 | 669,685 | $9,308,621 | |
| PRAX | Praxis Precision Medicines, Inc. | +35,200 | 56,267 | $18,128,664 | |
| QURE | uniQure N.V. | +34,581 | 78,066 | $1,276,379 | |
| ASMB | Assembly Biosciences, Inc. | +28,707 | 185,435 | $5,145,821 | |
| PHVS | Pharvaris N.V. | +28,248 | 86,637 | $2,447,495 | |
| SNDX | Syndax Pharmaceuticals Inc | +26,364 | 1,365,743 | $31,903,756 | |
| CAPR | Capricor Therapeutics, Inc. | +19,739 | 37,592 | $1,142,796 | |
| PTGX | Protagonist Therapeutics, Inc | +13,147 | 72,577 | $7,649,615 | |
| DNLI | Denali Therapeutics Inc. | +7,503 | 426,561 | $8,189,971 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +6,218 | 85,502 | $7,175,327 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | −580,898 | 385,800 | $10,686,660 | |
| WHWK | Whitehawk Therapeutics, Inc. | −519,438 | 939,369 | $3,240,823 | |
| TWST | Twist Bioscience Corp | −475,245 | 43,110 | $2,048,587 | |
| TERN | Terns Pharmaceuticals, Inc. | −329,198 | 100,000 | $5,272,000 | |
| DYN | Dyne Therapeutics, Inc. | −329,125 | 506,075 | $9,175,139 | |
| XENE | Xenon Pharmaceuticals Inc. | −207,850 | 140,755 | $8,184,903 | |
| GPCR | Structure Therapeutics Inc. | −150,806 | 200,267 | $9,652,869 | |
| SRZN | Surrozen, Inc./DE | −94,127 | 525,639 | $15,311,863 | |
| ABVX | Abivax S.A. | −77,992 | 313,791 | $34,940,627 | |
| EWTX | Edgewise Therapeutics, Inc. | −70,012 | 290,864 | $9,162,216 | |
| CELC | Celcuity Inc. | −58,271 | 60,062 | $6,855,476 | |
| XFOR | X4 Pharmaceuticals, Inc | −47,723 | 850,742 | $3,513,564 | |
| SRRK | Scholar Rock Holding Corp | −28,397 | 1,135,496 | $55,820,983 | |
| JNJ | Johnson & Johnson | −19,585 | 15,415 | $3,768,042 | |
| CYTK | Cytokinetics Inc | −17,401 | 129,577 | $8,540,420 | |
| AVTX | Avalo Therapeutics, Inc. | −810 | 134,742 | $2,011,698 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPY | Spdr S&P 500 ETF Trust | 50,000 | $32,517,000 | |
| QQQ | Invesco Qqq Trust, Series 1 | 40,000 | $23,087,200 | |
| BSX | Boston Scientific Corp | 250,000 | $15,687,500 | |
| ELVN | Enliven Therapeutics, Inc. | 363,438 | $14,246,769 | |
| CGON | CG Oncology, Inc. | 205,622 | $13,916,496 | |
| BHVN | Biohaven Ltd. | 1,594,491 | $13,489,393 | |
| TYRA | Tyra Biosciences, Inc. | 293,177 | $11,228,679 | |
| CLDX | Celldex Therapeutics, Inc. | 254,267 | $8,065,349 | |
| DFTX | Definium Therapeutics, Inc. | 325,483 | $6,151,628 | |
| BIOA | BioAge Labs, Inc. | 338,654 | $5,923,058 | |
| ACAD | Acadia Pharmaceuticals Inc | 242,566 | $5,399,519 | |
| ALMS | Alumis Inc. | 229,566 | $5,057,338 | |
| NRIX | Nurix Therapeutics, Inc. | 315,226 | $4,886,003 | |
| ZURA | Zura Bio Ltd | 753,520 | $4,483,444 | |
| TNGX | Tango Therapeutics, Inc. | 200,919 | $4,203,225 | |
| FTH | Faeth Therapeutics, Inc. | 132,873 | $4,188,156 | |
| RLMD | Relmada Therapeutics, Inc. | 597,409 | $4,157,966 | |
| ERAS | Erasca, Inc. | 239,861 | $3,880,950 | |
| PCVX | Vaxcyte, Inc. | 59,061 | $3,432,034 | |
| HLXC | Helix Acquisition Corp. III | 305,028 | $3,099,084 | |
| TENX | Tenax Therapeutics, Inc. | 188,700 | $3,017,313 | |
| ALKS | Alkermes plc. | 80,492 | $2,846,197 | |
| JBIO | Jade Biosciences, Inc. | 154,034 | $2,164,177 | |
| IONS | Ionis Pharmaceuticals Inc | 26,385 | $1,981,249 | |
| EW | Edwards Lifesciences Corp | 24,588 | $1,969,007 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 1,229,114 | $30,740,141 | |
| QNCX | Quince Therapeutics, Inc. | 739,264 | $24,765,344 | |
| ACLX | Arcellx, Inc. | 332,860 | $21,702,472 | |
| XLO | Xilio Therapeutics, Inc. | 2,030,028 | $18,189,050 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 17,736 | $10,328,382 | |
| ADPT | Adaptive Biotechnologies Corp | 606,825 | $9,854,838 | |
| PALI | Palisade Bio, Inc. | 4,192,375 | $9,852,081 | |
| DRUG | Bright Minds Biosciences Inc. | 97,340 | $7,596,413 | |
| NKTR | Nektar Therapeutics | 178,274 | $7,537,424 | |
| CLPT | ClearPoint Neuro, Inc. | 481,858 | $6,591,817 | |
| IMTX | Immatics N.V. | 610,308 | $6,408,234 | |
| OCUL | Ocular Therapeutix, Inc | 522,693 | $6,345,493 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 58,915 | $6,306,261 | |
| APGE | Apogee Therapeutics, Inc. | 80,574 | $6,081,725 | |
| INCY | Incyte Corp | 61,435 | $6,067,934 | |
| IDYA | IDEAYA Biosciences, Inc. | 161,659 | $5,588,551 | |
| MAZE | Maze Therapeutics, Inc. | 125,877 | $5,215,084 | |
| LLY | ELI LILLY & Co | 4,759 | $5,114,402 | |
| TRVI | Trevi Therapeutics, Inc. | 399,557 | $5,002,453 | |
| VRDN | Viridian Therapeutics, Inc.DE | 154,320 | $4,802,438 | |
| ABUS | Arbutus Biopharma Corp | 986,751 | $4,746,272 | |
| MLTX | MoonLake Immunotherapeutics | 348,401 | $4,591,925 | |
| CTMX | CytomX Therapeutics, Inc. | 1,036,311 | $4,414,684 | |
| ASND | Ascendis Pharma A/S | 14,842 | $3,164,908 | |
| RGEN | Repligen Corp | 15,707 | $2,573,749 | |
| No positions match the current search. | ||||
75 positions ·
$624,662,067 total
· as of Mar 31, 2026
Showing 1–50
of 75 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 1,135,496 | $55,820,983 | 8.94% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 381,632 | $37,113,712 | 5.94% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 313,791 | $34,940,627 | 5.59% | |
| SPY |
Spdr S&P 500 ETF Trust
|
NEW | 50,000 | $32,517,000 | 5.21% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 1,365,743 | $31,903,756 | 5.11% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
NEW | 40,000 | $23,087,200 | 3.70% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 846,494 | $21,026,910 | 3.37% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 56,267 | $18,128,664 | 2.90% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 250,000 | $15,687,500 | 2.51% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 525,639 | $15,311,863 | 2.45% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 499,469 | $14,909,149 | 2.39% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 533,378 | $14,449,210 | 2.31% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 363,438 | $14,246,769 | 2.28% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
NEW | 205,622 | $13,916,496 | 2.23% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 1,594,491 | $13,489,393 | 2.16% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 293,177 | $11,228,679 | 1.80% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 385,800 | $10,686,660 | 1.71% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 810,764 | $10,450,747 | 1.67% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 413,792 | $9,748,939 | 1.56% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 200,267 | $9,652,869 | 1.55% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 669,685 | $9,308,621 | 1.49% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 506,075 | $9,175,139 | 1.47% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 290,864 | $9,162,216 | 1.47% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 129,577 | $8,540,420 | 1.37% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Added | 167,606 | $8,454,046 | 1.35% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 426,561 | $8,189,971 | 1.31% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 140,755 | $8,184,903 | 1.31% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 254,267 | $8,065,349 | 1.29% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 72,577 | $7,649,615 | 1.22% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 85,502 | $7,175,327 | 1.15% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 60,062 | $6,855,476 | 1.10% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 325,483 | $6,151,628 | 0.98% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 338,654 | $5,923,058 | 0.95% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 180,658 | $5,782,862 | 0.93% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
NEW | 242,566 | $5,399,519 | 0.86% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 100,000 | $5,272,000 | 0.84% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 185,435 | $5,145,821 | 0.82% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 229,566 | $5,057,338 | 0.81% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 315,226 | $4,886,003 | 0.78% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
NEW | 753,520 | $4,483,444 | 0.72% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 193,777 | $4,454,933 | 0.71% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 200,919 | $4,203,225 | 0.67% | |
| FTH |
Faeth Therapeutics, Inc.
Healthcare
|
NEW | 132,873 | $4,188,156 | 0.67% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 597,409 | $4,157,966 | 0.67% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 239,861 | $3,880,950 | 0.62% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 15,415 | $3,768,042 | 0.60% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 850,742 | $3,513,564 | 0.56% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 59,061 | $3,432,034 | 0.55% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Reduced | 939,369 | $3,240,823 | 0.52% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
NEW | 305,028 | $3,099,084 | 0.50% |